DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /General ReagentsGeneral Reagents
  4. /Chelates & ComplexesChelates & Complexes
  5. /(p-SCN-Bn)-dota(p-SCN-Bn)-dota
Chemical structure of CAS 127985-74-4

(p-SCN-Bn)-dota

In Stock•Starting at $108 for 5 mg•Purity ≥ 95%
CAS No.127985-74-4
MDL No.MFCD11112156
MFC24H33N5O8S
MW551.60
InChI KeyUDOPJKHABYSVIX-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg95%$108In Stock
10 mg95%$183In Stock
25 mg95%$309In Stock
50 mg95%$522In Stock
100 mg95%$886In Stock
250 mg95%$1503In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.127985-74-4
Product Name(p-SCN-Bn)-dota
Heavy Atom Count38Rotatable Bond Count11
Atom Stereo Count1Bond Stereo Count0
HBA10HBD4
TPSA174.520 ŲCharge0
Exact Mass551.20498Complexity1017.57
pKa3.413XLogP-0.108

Related Articles

Studies related to this compound and its mechanism of action

PET imaging of soluble yttrium-86-labeled carbon nanotubes in mice.

PloS one • Vol. 2, Issue 9 • 2007
PMID: 17878942PMC: PMC1975469DOI: 10.1371/journal.pone.0000907

In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.

Nuclear medicine and biology • Vol. 34, Issue 3 • 2007
PMID: 17383579DOI: 10.1016/j.nucmedbio.2007.01.004

90Y Labeling of monoclonal antibody MOv18 and preclinical validation for radioimmunotherapy of human ovarian carcinomas.

Cancer immunology, immunotherapy : CII • Vol. 54, Issue 12 • 2005
PMID: 15926078PMC: PMC11034239DOI: 10.1007/s00262-005-0693-2

Targeted actinium-225 in vivo generators for therapy of ovarian cancer.

Cancer research • Vol. 63, Issue 16 • 2003
PMID: 12941838

Documentation

Similar Products

  • 2-[4,7-Bis(carboxymethyl)-5-[(4-isothiocyanatophenyl)methyl]-1,4,7-triazonan-1-yl]acetic acid

    CAS No.147597-66-8

  • (S)-p-SCN-Bn-DOTA

    CAS No.1020407-41-3

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact